Analysis of public microarray datasets revealed an increased expression of the carnitine palmitoyltransferase 1A (CPT1A), which catalyzes the first step of fatty acid oxidation, in the bone marrow, peripheral blood, and CD34+ cells of AML patients compared to healthy individuals. The gene discussed is CPT1A; the disease is acute myeloid leukemia.